INMB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 35.20%

Insider Buying (Last 12 Months): $236,436.60

Insider Selling (Last 12 Months): $0.00

INmune Bio Insider Trading History Chart

INmune Bio Share Price & Price History

^$4.57

▲ +0.01 (0.22%)

As of 11/21/2024 10:48 AM ET

Days: 30 | 90 | 365

JD Vance Predicts: Wall Street vs. Trump & Your Money

From Priority Gold | Ad

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.

INmune Bio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/30/2024	David J. Moss	CFO	Buy	10,000	$5.29	$52,900.00	1,285,869
9/12/2024	David J. Moss	CFO	Buy	7,690	$6.38	$49,062.20	1,275,869
9/12/2024	Raymond Joseph Tesi	CEO	Buy	15,380	$6.38	$98,124.40	1,554,106
6/25/2024	Scott Juda	Director	Buy	5,000	$7.27	$36,350.00	71,603
11/10/2023	Scott Juda	Director	Buy	7,000	$6.95	$48,650.00	37,000
7/12/2023	Timothy J. Schroeder	Director	Sell	10,000	$11.01	$110,100.00	82,187
3/17/2023	David J. Moss	CFO	Buy	2,500	$6.42	$16,050.00	1,250,151
5/26/2022	David J. Moss	CFO	Buy	7,700	$6.27	$48,279.00	1,244,651
5/26/2022	Raymond Joseph Tesi	CEO	Buy	6,300	$6.41	$40,383.00	1,520,698

Trump won. Buy this coin now.

From Weiss Ratings | Ad

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

This could be his favorite coin.

SEC Filings (Institutional Ownership Changes) for INmune Bio (NASDAQ:INMB)

12.72% of INmune Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

INmune Bio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/20/2024	Westside Investment Management Inc.	71,315	$0.38M	0.1%	+57.3%	0.322%
11/19/2024	Barclays PLC	29,044	$0.16M	0.0%	+601.9%	0.131%
11/16/2024	Geode Capital Management LLC	344,466	$1.86M	0.0%	+6.6%	1.554%
11/15/2024	Barclays PLC	29,044	$0.16M	0.0%	+601.9%	0.131%
11/15/2024	XTX Topco Ltd	46,253	$0.25M	0.0%	N/A	0.209%
11/15/2024	Jane Street Group LLC	14,725	$79K	0.0%	N/A	0.066%
11/15/2024	State Street Corp	226,428	$1.22M	0.0%	+35.1%	1.021%
11/14/2024	Praetorian PR LLC	780,800	$4.21M	1.6%	+61.0%	3.522%
11/12/2024	Charles Schwab Investment Management Inc.	33,990	$0.18M	0.0%	-8.8%	0.153%
10/25/2024	Financial Advocates Investment Management	13,500	$73K	0.0%	+17.4%	0.068%
10/9/2024	Fermata Advisors LLC	42,730	$0.23M	0.0%	+25.2%	0.216%
8/15/2024	CVI Holdings LLC	596,372	$5.26M	4.8%	N/A	3.015%
8/14/2024	Marshall Wace LLP	115,916	$1.02M	0.0%	+332.1%	0.586%
8/1/2024	Rhumbline Advisers	13,773	$0.12M	0.0%	N/A	0.070%
7/26/2024	Bank of New York Mellon Corp	58,600	$0.52M	0.0%	+124.6%	0.296%
7/17/2024	Westside Investment Management Inc.	45,340	$0.40M	0.1%	+31.8%	0.229%
7/13/2024	Fermata Advisors LLC	34,140	$0.30M	0.1%	+8.5%	0.173%
5/1/2024	Janney Montgomery Scott LLC	140,911	$1.66M	0.0%	-13.8%	0.774%
4/19/2024	Westside Investment Management Inc.	34,390	$0.40M	0.1%	-17.9%	0.189%
4/12/2024	Fermata Advisors LLC	31,451	$0.37M	0.1%	+6.9%	0.174%
2/8/2024	Financial Advocates Investment Management	12,500	$0.14M	0.0%	+8.6%	0.069%
2/8/2024	Janney Montgomery Scott LLC	163,559	$1.84M	0.0%	-36.3%	0.908%
1/19/2024	Fermata Advisors LLC	29,426	$0.33M	0.1%	-48.1%	0.163%
11/9/2023	Rhenman & Partners Asset Management AB	50,000	$0.34M	0.0%	-72.0%	0.277%
11/9/2023	Deutsche Bank AG	109,848	$0.74M	0.0%	-9.3%	0.610%
11/8/2023	Janney Montgomery Scott LLC	256,887	$1.74M	0.0%	+14.5%	1.426%
11/7/2023	Fermata Advisors LLC	56,702	$0.38M	0.1%	N/A	0.315%
10/24/2023	Bank of New York Mellon Corp	32,891	$0.22M	0.0%	N/A	0.183%
8/11/2023	Rhenman & Partners Asset Management AB	178,284	$1.62M	0.2%	N/A	0.989%
8/2/2023	MAI Capital Management	59,177	$0.54M	0.0%	+201.3%	0.330%
7/26/2023	Janney Montgomery Scott LLC	224,405	$2.04M	0.0%	-6.3%	1.250%
7/24/2023	Meitav Investment House Ltd.	181,140	$6.65M	0.1%	N/A	1.009%
7/14/2023	Westside Investment Management Inc.	42,240	$0.38M	0.1%	+13.8%	0.235%
5/11/2023	Financial Advocates Investment Management	11,500	$74K	0.0%	-15.8%	0.064%
5/10/2023	MAI Capital Management	19,643	$0.13M	0.0%	N/A	0.109%
4/28/2023	Janney Montgomery Scott LLC	239,448	$1.55M	0.0%	+6.6%	1.334%
2/3/2023	Sepio Capital LP	23,200	$0.15M	0.0%	-4.9%	0.129%
2/1/2023	Janney Montgomery Scott LLC	224,579	$1.42M	0.0%	+14.9%	1.251%
11/3/2022	ACT Capital Management LLC	151,100	$0.94M	1.3%	-5.9%	0.842%
10/28/2022	Sepio Capital LP	24,400	$0.15M	0.0%	+10.9%	0.136%
10/25/2022	Janney Montgomery Scott LLC	195,486	$1.21M	0.0%	-7.5%	1.089%
8/9/2022	Fermata Advisors LLC	24,011	$0.21M	0.1%	+22.6%	0.134%
8/4/2022	Northwestern Mutual Wealth Management Co.	4,300	$38K	0.0%	N/A	0.024%
8/3/2022	Janney Montgomery Scott LLC	211,318	$1.73M	0.0%	-18.9%	1.177%
7/26/2022	Sepio Capital LP	22,000	$0.19M	0.0%	N/A	0.123%
7/15/2022	Westside Investment Management Inc.	30,140	$0.27M	0.0%	+14.2%	0.168%
4/25/2022	Westside Investment Management Inc.	26,390	$0.22M	0.0%	+238.3%	0.148%
4/22/2022	Fermata Advisors LLC	19,586	$0.17M	0.1%	+9.1%	0.110%
2/15/2022	Westside Investment Management Inc.	7,800	$79K	0.0%	N/A	0.044%
2/9/2022	Alps Advisors Inc.	20,650	$0.21M	0.0%	-4.8%	0.116%
2/3/2022	Advisor Group Holdings Inc.	35,738	$0.36M	0.0%	+193.7%	0.200%
2/3/2022	ACT Capital Management LLC	230,500	$2.35M	1.7%	-16.2%	1.292%
2/2/2022	Fermata Advisors LLC	17,955	$0.18M	0.1%	+39.9%	0.101%
1/27/2022	Janney Montgomery Scott LLC	113,914	$1.16M	0.0%	+14.7%	0.638%
11/16/2021	Migdal Insurance & Financial Holdings Ltd.	1,608	$31K	0.0%	N/A	0.009%
11/16/2021	ACT Capital L.L.C.	275,000	$5.34M	2.8%	N/A	1.541%
11/16/2021	Millennium Management LLC	123,511	$2.40M	0.0%	N/A	0.692%
11/15/2021	Cubist Systematic Strategies LLC	19,989	$0.39M	0.0%	N/A	0.112%
11/15/2021	Marshall Wace LLP	64,650	$1.26M	0.0%	N/A	0.362%
11/15/2021	Royal Bank of Canada	126,411	$2.46M	0.0%	+90.2%	0.708%
11/12/2021	Geode Capital Management LLC	89,607	$1.74M	0.0%	+21.4%	0.502%
11/12/2021	DG Capital Management LLC	20,000	$0.39M	0.1%	N/A	0.112%
11/9/2021	BlackRock Inc.	146,429	$2.84M	0.0%	-20.4%	0.821%
11/5/2021	Advisor Group Holdings Inc.	12,170	$0.24M	0.0%	-55.4%	0.068%
11/4/2021	Financial Advocates Investment Management	16,667	$0.32M	0.0%	-15.3%	0.093%
10/29/2021	Fermata Advisors LLC	12,830	$0.25M	0.1%	+9.2%	0.072%
10/29/2021	Janney Montgomery Scott LLC	99,323	$1.93M	0.0%	+73.2%	0.557%
10/19/2021	Belvedere Trading LLC	16,177	$0.30M	0.0%	-42.2%	0.091%
9/17/2021	Virtu Financial LLC	10,530	$0.19M	0.0%	N/A	0.059%
8/18/2021	Ikarian Capital LLC	146,883	$2.58M	0.2%	-37.1%	0.830%
8/17/2021	Boothbay Fund Management LLC	24,158	$0.42M	0.0%	-24.7%	0.136%
8/16/2021	Royal Bank of Canada	66,458	$1.17M	0.0%	+1.4%	0.375%
8/16/2021	Morgan Stanley	11,543	$0.20M	0.0%	+273.2%	0.065%
8/16/2021	State Street Corp	34,816	$0.61M	0.0%	N/A	0.197%
8/13/2021	Altium Capital Management LP	52,257	$0.92M	0.2%	N/A	0.295%
8/13/2021	Geode Capital Management LLC	73,794	$1.30M	0.0%	+21.3%	0.417%
8/13/2021	Vanguard Group Inc.	379,168	$6.66M	0.0%	+21.1%	2.142%
8/13/2021	EAM Global Investors LLC	116,809	$2.05M	0.6%	N/A	0.660%
8/13/2021	EAM Investors LLC	161,793	$2.84M	0.4%	N/A	0.914%
8/12/2021	Advisory Services Network LLC	3,108	$55K	0.0%	N/A	0.018%
8/11/2021	BlackRock Inc.	184,006	$3.23M	0.0%	-16.3%	1.039%
8/11/2021	Susquehanna International Group LLP	75,714	$1.33M	0.0%	+128.9%	0.428%
8/10/2021	Fermata Advisors LLC	11,750	$0.21M	0.1%	N/A	0.066%
8/2/2021	Advisor Group Holdings Inc.	27,262	$0.48M	0.0%	+241.5%	0.172%
7/31/2021	Marino Stram & Associates LLC	10,369	$0.18M	0.0%	N/A	0.065%
5/18/2021	Millennium Management LLC	41,988	$0.50M	0.0%	N/A	0.281%
5/18/2021	Jane Street Group LLC	12,221	$0.15M	0.0%	N/A	0.082%
5/17/2021	Royal Bank of Canada	65,548	$0.78M	0.0%	+15.0%	0.439%
5/17/2021	HRT Financial LP	22,055	$0.26M	0.0%	N/A	0.148%
5/17/2021	Ikarian Capital LLC	233,576	$2.78M	0.1%	+7.4%	1.564%
5/13/2021	Bank of Montreal Can	47,076	$0.54M	0.0%	-22.5%	0.315%
5/12/2021	Northern Trust Corp	13,949	$0.17M	0.0%	+12.7%	0.093%
5/12/2021	Geode Capital Management LLC	60,837	$0.72M	0.0%	+80.8%	0.407%
5/12/2021	UBS Group AG	3,309	$39K	0.0%	+1,223.6%	0.022%
5/10/2021	Financial Advocates Investment Management	19,667	$0.23M	0.0%	+8.3%	0.132%
5/7/2021	BlackRock Inc.	219,730	$2.61M	0.0%	+934.4%	1.471%
4/12/2021	FNY Investment Advisers LLC	6,200	$73K	0.0%	+40.9%	0.042%
3/8/2021	Dimensional Fund Advisors LP	11,052	$0.19M	0.0%	-31.0%	0.082%
3/2/2021	Capital Asset Advisory Services LLC	1,875	$32K	0.0%	N/A	0.014%
2/25/2021	Dimensional Fund Advisors LP	11,052	$0.19M	0.0%	-31.0%	0.082%

Data available starting January 2016

INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, a mucinous polyglucan on the surface of some epithelial cancer cells that appears to predict resistant to immunotherapy, including women with MUC4 expressing HER2+ breast cancer and other MUC4 resistant cancers. It also provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.

Today's Range

Now: $4.57

$4.56

$4.59

50 Day Range

MA: $5.43

$4.56

$6.43

52 Week Range

Now: $4.57

$4.45

$14.74

Volume

25,491 shs

Average Volume

165,114 shs

Market Capitalization

$101.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.85

Who are the company insiders with the largest holdings of INmune Bio?: INmune Bio's top insider shareholders include:
Raymond Joseph Tesi (CEO)
David J Moss (CFO)
Timothy J Schroeder (Director)
Scott Juda (Director)
Learn More about top insider investors at INmune Bio.
Who are the major institutional investors of INmune Bio?: INmune Bio's top institutional investors include:
Praetorian PR LLC — 3.52%
Geode Capital Management LLC — 1.55%
State Street Corp — 1.02%
Westside Investment Management Inc. — 0.32%
XTX Topco Ltd — 0.21%
Fermata Advisors LLC — 0.22%
Learn More about top institutional investors of INmune Bio stock.
Which institutional investors are selling INmune Bio stock?: Within the previous quarter, INMB stock was sold by these institutional investors:
Charles Schwab Investment Management Inc.
Which institutional investors are buying INmune Bio stock?: Within the last quarter, INMB stock was purchased by institutional investors including:
Praetorian PR LLC
State Street Corp
XTX Topco Ltd
Westside Investment Management Inc.
Barclays PLC
Barclays PLC
Geode Capital Management LLC
Jane Street Group LLC
Within the last year, these company insiders have bought INmune Bio stock:
Raymond Joseph Tesi (CEO)
David J Moss (CFO)
Timothy J Schroeder (Director)
Learn More investors buying INmune Bio stock.